Showing results (1291-1300 of 1,308) with videos related to

Sort By:
Pageof 131
Nature Cancer|February 28, 2022
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncologyKatrin P Guillen, Maihi Fujita, Andrew J Butterfield, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 28, 2021
A Multi-center Genome-wide Association Study of Cervical DystoniaYan V Sun, Chengchen Li, Qin Hui, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Plos Genetics|March 23, 2012
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene databaseChristina M Lill, Johannes T Roehr, Matthew B McQueen, et al.
Archives of Neurology|July 21, 2004
Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trialRobert G Holloway, Ira Shoulson, Stanley Fahn, et al.
Environment International|March 25, 2025
Periods of susceptibility for associations between phthalate exposure and preterm birth: Results from a pooled analysis of 16 US cohortsAlexa Friedman, Barrett M Welch, Alexander P Keil, et al.
JAMA Pediatrics|July 11, 2022
Associations Between Prenatal Urinary Biomarkers of Phthalate Exposure and Preterm Birth: A Pooled Study of 16 US CohortsBarrett M Welch, Alexander P Keil, Jessie P Buckley, et al.
Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.
Environmental Health Perspectives|December 20, 2023
Racial and Ethnic Disparities in Phthalate Exposure and Preterm Birth: A Pooled Study of Sixteen U.S. CohortsBarrett M Welch, Alexander P Keil, Jessie P Buckley, et al.
Pageof 131